Vanguard Capital Management’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
Vanguard Capital Management's ORGO Position: Q3 2026 in Review
Vanguard Capital Management increased its Organogenesis Holdings (ORGO) stake by 1.4% in Q3 2026, buying an estimated $78.9K and bringing the position to 2,946,084 shares worth $4.04M. The position accounts for ﹤0.01% of the portfolio, ranked #3146.
Vanguard Capital Management first reported a position in ORGO in Q1 2026 and has held it in 3 quarters since. The position peaked at $7.06M in Q2 2026. 123 funds tracked by Wall St. Rank hold ORGO as of Q3 2026.
- Vanguard Capital Management held 2,946,084 shares of Organogenesis Holdings worth $4.04M as of Q3 2026.
- Vanguard Capital Management bought 40,165 Organogenesis Holdings shares in Q3 2026, an estimated $78.9K.
- Organogenesis Holdings made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3146 holding.
- Vanguard Capital Management first reported a position in Organogenesis Holdings in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Organogenesis Holdings position peaked at $7.06M in Q2 2026.
- 123 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.